Literature DB >> 17047168

Role of noradrenergic pathways in sneeze-induced urethral continence reflex in rats.

Yasuhiro Kaiho1, Izumi Kamo, Michael B Chancellor, Yoichi Arai, William C de Groat, Naoki Yoshimura.   

Abstract

To clarify the role of noradrenergic pathways in preventing stress urinary incontinence (SUI) during sneezing, we investigated the effect of the norepinephrine reuptake inhibitor nisoxetine and alpha-adrenoceptor antagonists phentolamine (nonspecific blocker) and prazosin (alpha(1)-receptor-selective blocker) on the neurally evoked urethral continence reflex induced by sneezing in rats. The amplitude of urethral pressure responses during sneezing (A-URS), urethral baseline pressure (UBP) at the midurethra, and sneeze-induced leak point pressure (S-LPP) were measured in normal female adult rats and rats with SUI induced by vaginal distention (VD). In normal rats, intrathecal (it) phentolamine (0.02 nmol) and prazosin (0.02 nmol) decreased A-URS by 11.9 and 15.7%, respectively, without affecting UBP. In both normal and VD rats, intravenous (iv) application of nisoxetine (1 mg/kg) increased A-URS by 17.2 and 18.3% and UBP by 23.7 and 32.7%, respectively. Phentolamine or prazosin (both it) eliminated nisoxetine-induced increases in A-URS, but not the increases in UBP, which were, however, suppressed by iv phentolamine (5 mg/kg) or prazosin (1 mg/kg). Sneezing induced fluid leakage from the urethral orifice in VD rats, but not in normal rats. In VD rats, S-LPP was increased by 30.2% by iv nisoxetine. Application of phentolamine and prazosin (both it) decreased S-LPP by 15.7 and 20.6%, respectively, and nisoxetine induced increases in S-LPP to 13.2 and 12.3%, respectively. These results indicate that activation of the noradrenergic system by a norepinephrine reuptake inhibitor can prevent SUI via alpha(1-)adrenoceptors by enhancing the sneeze-induced active urethral closure mechanism at the spinal level and augmenting UBP at the periphery.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17047168     DOI: 10.1152/ajprenal.00226.2006

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  26 in total

1.  Properties of urethral rhabdosphincter motoneurons and their regulation by noradrenaline.

Authors:  Koji Yashiro; Karl B Thor; Edward C Burgard
Journal:  J Physiol       Date:  2010-10-25       Impact factor: 5.182

Review 2.  The promise of stem cell therapy to restore urethral sphincter function.

Authors:  Akira Furuta; Ron J Jankowski; Ryan Pruchnic; Naoki Yoshimura; Michael B Chancellor
Journal:  Curr Urol Rep       Date:  2007-09       Impact factor: 3.092

Review 3.  Neural control of the lower urinary tract.

Authors:  William C de Groat; Derek Griffiths; Naoki Yoshimura
Journal:  Compr Physiol       Date:  2015-01       Impact factor: 9.090

4.  Effects of a selective androgen receptor modulator (SARM), GSK2849466A, on stress urinary incontinence and bladder activity in rats with ovariectomy-induced oestrogen deficiency.

Authors:  Katsumi Kadekawa; Naoki Kawamorita; Takahiro Shimizu; Masahiro Kurobe; Philip S Turnbull; Sundeep Chandra; Takahito Kambara; Joanna C Barton; Alan J Russell; Naoki Yoshimura
Journal:  BJU Int       Date:  2020-03-20       Impact factor: 5.588

5.  Urethral compensatory mechanisms to maintain urinary continence after pudendal nerve injury in female rats.

Authors:  Akira Furuta; Yasuyuki Suzuki; Koji Asano; William C de Groat; Shin Egawa; Naoki Yoshimura
Journal:  Int Urogynecol J       Date:  2011-03-29       Impact factor: 2.894

6.  Effects of propiverine hydrochloride, an anticholinergic agent, on urethral continence mechanisms and plasma catecholamine concentration in rats.

Authors:  Takeya Kitta; Vikas Tyagi; Masato Nanri; Mamoru Kiniwa; Katsuya Nonomura; Naoki Yoshimura
Journal:  Int Urogynecol J       Date:  2012-08-29       Impact factor: 2.894

7.  Effects of phosphodiesterase type 5 inhibitor, tadalafil, on continence reflex in rats.

Authors:  Hideaki Izumi; Yasuhiro Kaiho; Minoru Miyazato; Naoki Kawamorita; Haruo Nakagawa; Yoichi Arai
Journal:  Int Urogynecol J       Date:  2014-07-03       Impact factor: 2.894

Review 8.  Coadministration of low-dose serotonin/noradrenaline reuptake inhibitor (SNRI) duloxetine with α 2-adrenoceptor blockers to treat both female and male mild-to-moderate stress urinary incontinence (SUI).

Authors:  C Alberti
Journal:  G Chir       Date:  2013 Jul-Aug

Review 9.  Animal models of female stress urinary incontinence.

Authors:  Adonis Hijaz; Firouz Daneshgari; Karl-Dietrich Sievert; Margot S Damaser
Journal:  J Urol       Date:  2008-04-18       Impact factor: 7.450

Review 10.  Therapeutic receptor targets for lower urinary tract dysfunction.

Authors:  Naoki Yoshimura; Yasuhiro Kaiho; Minoru Miyazato; Takakazu Yunoki; Changfeng Tai; Michael B Chancellor; Pradeep Tyagi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-11-21       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.